Skip to content
Clinical Trials – home

Medic-Center Nürnberg

Verified siteinfo

Germany Gibitzenhofstr. 62, 90443 Nürnberg, Germany

  • Chronic kidney disease · Hypertension · Type 2 diabetes mellitus
  • Adult patients

About Specializations

Medic-Center Nürnberg in Nürnberg, Germany specialises in clinical trials of conditions such as Chronic kidney disease, Hypertension, Type 2 diabetes mellitus, Obesity, and other specialisations. This site conducts important research.

Main research areas of the site

Nephrology and Hypertension

The medical center is at the forefront of research in nephrology and hypertension, focusing on innovative treatments for chronic kidney disease (CKD) and high blood pressure. The center's work aims to improve patient outcomes through advanced therapeutic strategies.

  • Chronic Kidney Disease Management
  • Hypertension Control
  • Renal Function Preservation

By exploring the efficacy of novel drug combinations, the center contributes significantly to the understanding and management of kidney-related conditions, enhancing the quality of life for patients worldwide.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Gibitzenhofstr. 6290443 NürnbergGermany
Recruiting now
no trials
Conditions studied
5
Partner status
Verified site

More sites in NürnbergGermany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Chronic kidney disease+1

Not recruiting

Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Type 2 diabetes mellitus+3

Not recruiting

Evaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Canagliflozin
  • Sponsor:Eli Lilly & Co.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.